Cite
Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook
MLA
Emil Ruvinov, and Smadar Cohen. “Alginate Biomaterial for the Treatment of Myocardial Infarction: Progress, Translational Strategies, and Clinical Outlook.” Advanced Drug Delivery Reviews, vol. 96, Jan. 2016, pp. 54–76. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........47302797a3f66b203e030017a68c4101&authtype=sso&custid=ns315887.
APA
Emil Ruvinov, & Smadar Cohen. (2016). Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook. Advanced Drug Delivery Reviews, 96, 54–76.
Chicago
Emil Ruvinov, and Smadar Cohen. 2016. “Alginate Biomaterial for the Treatment of Myocardial Infarction: Progress, Translational Strategies, and Clinical Outlook.” Advanced Drug Delivery Reviews 96 (January): 54–76. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........47302797a3f66b203e030017a68c4101&authtype=sso&custid=ns315887.